Zobrazeno 1 - 10
of 3 002
pro vyhledávání: '"selective serotonin reuptake inhibitor"'
Autor:
Fang-Ling Li, Yu-Tse Sheih, Ming-Hsun Lin, Yong-Chen Chen, Wen-Tung Wu, Tsung-Kun Lin, Yu‐Ching Chou, Chien‐An Sun
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background We explored if the administration of fluoxetine, recognized for its potential in adipocyte browning, entails a differential risk of coronary heart disease (CHD) in comparison to other SSRI medications. Methods Using the National H
Externí odkaz:
https://doaj.org/article/df6a2c72a10b41319100c92fbc7e4468
Autor:
Jones, Owen D., author, Schall, Jeffrey D., author, Shen, Francis X., author, Hoffman, Morris B., author, Wagner, Anthony D., author
Publikováno v:
Brain Science for Lawyers, Judges, and Policymakers, 2024, ill.
Externí odkaz:
https://doi.org/10.1093/oso/9780197748855.003.0005
Autor:
Katherine J. P. Schwenger, Yasaman Ghorbani, Fadi Alkass, Tulasi Patel, Timothy D. Jackson, Allan Okrainec, Johane P. Allard
Publikováno v:
Eating and Weight Disorders, Vol 29, Iss 1, Pp 1-7 (2024)
Abstract Purpose Depression is prevalent in patients undergoing bariatric surgery (BSx). Long-term use of antidepressant is associated with weight gain, particularly the use of selective serotonin reuptake inhibitors (SSRIs). Little is known about wh
Externí odkaz:
https://doaj.org/article/6f182ebfe9644ce1bea1a9eacc419922
Autor:
Lubova Renemane, Elmars Rancans
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
This case report describes a patient with major depressive disorder (MDD) who developed acute hepatocellular liver injury after being treated with sertraline, a selective serotonin reuptake inhibitor (SSRI). The diagnosis of MDD was made two years pr
Externí odkaz:
https://doaj.org/article/c814d7e5df654ecdbcdf9885a1530dd1
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 246-249 (2024)
Abstract Vascular endothelial growth factor (VEGF) signaling is known to be involved in the antidepressant‐like effects of conventional antidepressants, such as desipramine (DMI), a tricyclic antidepressant, and fluoxetine (FLX), a selective seroto
Externí odkaz:
https://doaj.org/article/cc74544c92bd4e53b9bdb78a800dac3e
Autor:
Mark T. Waddingham, Hirotsugu Tsuchimochi, Takashi Sonobe, Vasco Sequeira, Md Junayed Nayeem, Mikiyasu Shirai, James T. Pearson, Takeshi Ogo
Publikováno v:
Journal of Molecular and Cellular Cardiology Plus, Vol 8, Iss , Pp 100072- (2024)
Background: Pulmonary hypertension (PH) often leads to right ventricle (RV) failure, a significant cause of morbidity and mortality. Despite advancements in PH management, progression to RV maladaptation and subsequent failure remain a clinical chall
Externí odkaz:
https://doaj.org/article/c799fd064dab4b7da859a49b8d77c099
Autor:
Syed Faraz Zafar, Michelle Ahmed
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 74, Iss 2 (2024)
response to standard first-line treatments. We report a case of treatment-refractory OCD that was successfully treated with the pharmacological strategy of using selective serotonin reuptake inhibitors (SSRIs) in the above-licensed doses. Patient, a
Externí odkaz:
https://doaj.org/article/bec935a5552c490db542820982f60dbe
Publikováno v:
World Neurosurgery: X, Vol 22, Iss , Pp 100309- (2024)
Introduction: Prior studies have identified SSRI use as a risk factor for certain adverse bleeding outcomes. However, the risk of significant bleeding from perioperative SSRI use after brain tumor resection remains largely undetermined. This study ev
Externí odkaz:
https://doaj.org/article/eac62de21e5642d0bcb177713267420c
Publikováno v:
Annals of Indian Psychiatry, Vol 8, Iss 1, Pp 74-76 (2024)
Paroxetine is a commonly used drug in psychiatric settings for disorders such as major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, generalized anxiety disorder, panic disorder, premenstrual dysphoric disorder, and pos
Externí odkaz:
https://doaj.org/article/3712e4af20934e15902b4754eca3f444
Autor:
Ping Guo, Yong Xu, Liang Lv, Min Feng, Yu Fang, Wei-Quan Huang, Shan-Fei Cheng, Min-Cai Qian, Shengliang Yang, Shi-Kai Wang, Huan-Xin Chen
Publikováno v:
Annals of General Psychiatry, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Objective To evaluate the clinical efficacy and safety of Agomelatine in improving symptoms in patients with major depressive disorder (MDD), providing more scientific evidence for the treatment of depression, and offering more effective the
Externí odkaz:
https://doaj.org/article/62092851747745c8b1c57ec2019adca5